Search research articles
Contact Us
Filters
Showing results (161-170 of 190) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Investigation
|
July 19, 2013
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Rebecca L Williams-Karnesky, Ursula S Sandau, Theresa A Lusardi, et al.
Pharmacological Reviews
|
October 30, 2025
Erratum to "Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions" [Pharmacological Reviews 77 (2025) 100080]
Doodipala Samba Reddy, Victoria M Golub, Sreevidya Ramakrishnan, et al.
Pharmacological Reviews
|
August 1, 2025
Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions
Doodipala Samba Reddy, Victoria M Golub, Sreevidya Ramakrishnan, et al.
Scientific Reports
|
January 13, 2026
Commonalities in gene expression and methylation changes across two rat models of acquired epilepsy
Benton S Purnell, Junguk Hur, David Ruskin, et al.
Biological Psychiatry
|
April 15, 2015
Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia
Marco Matos, Hai-Ying Shen, Elisabete Augusto, et al.
The Journal of Clinical Investigation
|
June 19, 2012
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia
Hai-Ying Shen, Philipp Singer, Nikki Lytle, et al.
Epilepsia
|
June 4, 2011
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy
Eleonora Aronica, Emanuele Zurolo, Anand Iyer, et al.
Journal of Caffeine and Adenosine Research
|
June 23, 2020
Role of Adenosine in Epilepsy and Seizures
Fabio C Tescarollo, Diogo M Rombo, Lindsay K DeLiberto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Adenosine A<sub>2A</sub> receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function
Alfredo Oliveros, Ki Hyun Yoo, Mohammad Abdur Rashid, et al.
Biochemical Society Transactions
|
March 21, 2014
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Vanessa Flaten, Cyril Laurent, Joana E Coelho, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 190) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Investigation
|
July 19, 2013
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Rebecca L Williams-Karnesky, Ursula S Sandau, Theresa A Lusardi, et al.
Pharmacological Reviews
|
October 30, 2025
Erratum to "Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions" [Pharmacological Reviews 77 (2025) 100080]
Doodipala Samba Reddy, Victoria M Golub, Sreevidya Ramakrishnan, et al.
Pharmacological Reviews
|
August 1, 2025
Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions
Doodipala Samba Reddy, Victoria M Golub, Sreevidya Ramakrishnan, et al.
Scientific Reports
|
January 13, 2026
Commonalities in gene expression and methylation changes across two rat models of acquired epilepsy
Benton S Purnell, Junguk Hur, David Ruskin, et al.
Biological Psychiatry
|
April 15, 2015
Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia
Marco Matos, Hai-Ying Shen, Elisabete Augusto, et al.
The Journal of Clinical Investigation
|
June 19, 2012
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia
Hai-Ying Shen, Philipp Singer, Nikki Lytle, et al.
Epilepsia
|
June 4, 2011
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy
Eleonora Aronica, Emanuele Zurolo, Anand Iyer, et al.
Journal of Caffeine and Adenosine Research
|
June 23, 2020
Role of Adenosine in Epilepsy and Seizures
Fabio C Tescarollo, Diogo M Rombo, Lindsay K DeLiberto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Adenosine A<sub>2A</sub> receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function
Alfredo Oliveros, Ki Hyun Yoo, Mohammad Abdur Rashid, et al.
Biochemical Society Transactions
|
March 21, 2014
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Vanessa Flaten, Cyril Laurent, Joana E Coelho, et al.
Page
of 19